Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
97,693,461
-
Total 13F shares
-
1,240,919
-
Share change
-
+41,618
-
Total reported value
-
$20,288,000
-
Price per share
-
$16.35
-
Number of holders
-
21
-
Value change
-
+$544,189
-
Number of buys
-
14
-
Number of sells
-
5
Institutional Holders of Rani Therapeutics Holdings, Inc. - Common Stock (RANI) as of Q4 2021
As of 31 Dec 2021,
Rani Therapeutics Holdings, Inc. - Common Stock (RANI) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,240,919 shares.
The largest 10 holders included
Nan Fung Group Holdings Ltd, VANGUARD GROUP INC, BlackRock Inc., Alpha Square Group S, LLC, GEODE CAPITAL MANAGEMENT, LLC, Squarepoint Ops LLC, STIFEL FINANCIAL CORP, ADVISOR GROUP HOLDINGS, INC., STATE STREET CORP, and CAAS CAPITAL MANAGEMENT LP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.